secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0001683168-24-007304
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharma faces Nasdaq delisting for bid price deficiency; hearing Nov 5
-------------------------------------------------------------------------

- Received Nasdaq notice on Sept 12, 2024, for failing minimum $1.00 bid price for 30 consecutive days.
- Ineligible for 180-day cure period due to reverse stock splits >250:1 cumulative ratio in prior two years.
- Hearing before Nasdaq Panel scheduled for Nov 5, 2024; automatically stays suspension or delisting pending hearing.
- No assurance that Panel will grant an additional compliance extension beyond the hearing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824007304/0001683168-24-007304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824007304/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-007304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer